Dr. Neppalli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3427
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Hematopathology, 2004 - 2006
- University of MinnesotaResidency, Pathology-Anatomic and Clinical, 2000 - 2004
- Siddhartha Medical College NTRClass of 1994
Certifications & Licensure
- NY State Medical License 2010 - 2025
- IA State Medical License 2006 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 25 citationsPevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivoNatalie M Czuczman, Matthew J. Barth, Juan Gu, Vishala T. Neppalli, Cory Mavis
Blood. 2016-03-03 - 50 citationsReappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A series of 10 adult and pediatric patients and review of the li...Christian L. Baum, Brian K. Link, Vishala T. Neppalli, Brian L. Swick, Vincent Liu
Journal of the American Academy of Dermatology. 2011-10-01 - 105 citationsMultiple Myeloma, version 3.2018: Featured updates to the NCCN guidelinesShaji Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann
Journal of the National Comprehensive Cancer Network. 2018-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: